Mylan Pharma GMBH
- A02 - Agentes para el tratamiento de alteraciones causadas por ácidos
- PANTOPRAZOL VIATRIS gastro-resistant tablet 20 mg
- PANTOPRAZOL VIATRIS gastro-resistant tablet 40 mg
- A06 - Agentes contra el estreñimiento
- DUPHALAC syrup 667 mg/ml
- B01 - Agentes antitrombóticos
- FRAXIPARINE PRE FILLED SYRINGE solution for injection 1 900 IU Anti-Xa/0.2 ml
- FRAXIPARINE PRE FILLED SYRINGE solution for injection 2 850 IU Anti-Xa/0.3 ml
- FRAXIPARINE PRE FILLED SYRINGE solution for injection 3 800 IU Anti-Xa/0.4 ml
- FRAXIPARINE PRE FILLED SYRINGE solution for injection 5 700 IU Anti-Xa/0.6 ml
- FRAXIPARINE PRE FILLED SYRINGE solution for injection 7 600 IU Anti-Xa/0.8 ml
- FRAXIPARINE PRE FILLED SYRINGE solution for injection 9 500 IU Anti-Xa/1 ml
- INHIXA MULTI solution for injection 30 000 IU (300 mg)/3 ml
- INHIXA solution for injection 10 000 IU (100 mg)/1 ml
- INHIXA solution for injection 12 000 IU (120 mg)/0.8 ml
- INHIXA solution for injection 15 000 IU (150 mg)/1 ml
- INHIXA solution for injection 2 000 IU (20 mg)/0.2 ml
- INHIXA solution for injection 4 000 IU (40 mg)/0.4 ml
- INHIXA solution for injection 6 000 IU (60 mg)/0.6 ml
- INHIXA solution for injection 8 000 IU (80 mg)/0.8 ml
- C01 - Terapia cardíaca
- IVABRADIN MYLAN film-coated tablet 5 mg
- IVABRADIN MYLAN film-coated tablet 7.5 mg
- C03 - Diuréticos
- TORASEMID MYLAN tablet 10 mg
- TORASEMID MYLAN tablet 2.5 mg
- TORASEMID MYLAN tablet 200 mg
- TORASEMID MYLAN tablet 5 mg
- C08 - Bloqueantes del canal de calcio
- ISOPTIN film-coated tablet 80 mg
- ISOPTIN RETARD prolonged-release tablet 120 mg
- ISOPTIN RR RETARD prolonged-release tablet 240 mg
- C10 - Agentes modificadores de los lípidos
- ROSUVASTATIN VIATRIS film-coated tablet 10 mg
- ROSUVASTATIN VIATRIS film-coated tablet 20 mg
- ROSUVASTATIN VIATRIS film-coated tablet 5 mg
- TRILIPIX prolonged-release capsule, hard 135 mg
- TRILIPIX prolonged-release capsule, hard 45 mg
- G03 - Hormonas sexuales y moduladores del sistema genital
- DIENOGEST MYLAN tablet 2 mg
- G04 - Urológicos
- TAMSULOSIN MYLAN prolonged-release capsule, hard 0.4 mg
- J01 - Antibacterianos para uso sistémico
- KLACID film-coated tablet 250 mg
- KLACID film-coated tablet 500 mg
- KLACID ONE prolonged-release tablet 500 mg
- KLACID powder for solution for infusion 500 mg
- KLACIPED FORTE granules for oral suspension 250 mg/5 ml
- KLACIPED granules for oral suspension 125 mg/5 ml
- J02 - Antimicóticos de uso sistémico
- CASPOFUNGIN MYLAN powder for solution for infusion 50 mg
- CASPOFUNGIN MYLAN powder for solution for infusion 70 mg
- J07 - Vacunas
- INFLUVAC suspension for injection
- L01 - Antineoplásicos
- IMATINIB MYLAN film-coated tablet 100 mg
- IMATINIB MYLAN film-coated tablet 400 mg
- L02 - Terapia endocrina
- FULVESTRANT MYLAN solution for injection 250 mg/5 ml
- L03 - Inmunoestimulantes
- FULPHILA PREFILLED SYRINGE solution for injection 6 mg/0.6 ml
- GLATIRAMYL solution for injection 20 mg/1 ml
- GLATIRAMYL solution for injection 40 mg/1 ml
- L04 - Inmunosupresores
- HULIO solution for injection 40 mg/0.8 ml
- M01 - Antiinflamatorios y antirreumáticos
- FROBEN coated tablet 100 mg
- FROBEN coated tablet 50 mg
- IBUPROFEN MYLAN effervescent tablet 600 mg
- IBUPROFEN MYLAN film-coated tablet 200 mg
- IBUPROFEN MYLAN film-coated tablet 400 mg
- IBUPROFEN MYLAN film-coated tablet 600 mg
- IBUPROFEN MYLAN prolonged-release tablet 800 mg
- N06 - Psicoanalépticos
- DULOXETIN VIATRIS gastro-resistant capsule, hard 30 mg
- DULOXETIN VIATRIS gastro-resistant capsule, hard 60 mg
- ESCITALOPRAM VIATRIS film-coated tablet 10 mg
- ESCITALOPRAM VIATRIS film-coated tablet 20 mg